Full name
PDG CETUS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
PDG CETUS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. SOKRATESA 11B / 251, 01-909 WARSZAWA
TAX ID1182132600
Rate company:
PDG CETUS PHARMA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID1182132600
KRS0000645878
Share capital100,000.00 zł
address
UL. SOKRATESA 11B / 251, 01-909 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
1182132600
REGON
365824617
KRS
0000645878
Legal form
limited liability company
Register Address
UL. SOKRATESA 11B / 251, 01-909 WARSZAWA
Date of registration in KRS
2016-11-09
Date of commencement of economic activity
2016-11-09
Act signature
WA.XIV NS-REJ.KRS/30275/22/483/ADE
Pkd codes
70.22.Z - Head office activities and management consultancy
10.89.Z - Production of other food products, not elsewhere classified
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.39.Z - Wholesale trade of non-specialized food, beverages, and tobacco products
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.75.Z - Wholesale trade
70.21.Z - Head office activities and management consultancy
71.20.B - Inspection and issuing opinions on the technical condition of chimneys and ventilation ducts
73.1 - Advertising
82.99.Z - Other business support activities, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL10 1050 1025 1000 0090 8010 0457 
PL81 1050 1025 1000 0090 8010 0440 PL85 1050 1025 1000 0090 8010 0465 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0,7 | 0,1 | -0,4 | -562,2 |
EBITDA | -0,8 | 0,1 | -0,4 | -627,6 |
Short time liabilities | 0,2 | 0,1 | 0,1 | 46,4 |
Income tax | -58,7 | |||
Equity capital | 0,7 | 0,7 | 0,3 | -53,3 |
Operating profit (EBIT) | -0,8 | 0,1 | -0,4 | -640,4 |
Assets | 0,8 | 0,8 | 0,4 | -46,8 |
Net profit (loss) | -0,7 | 0,1 | -0,4 | -562,2 |
Cash | 0,2 | 0 | 0 | 13,8 |
Net income from sale | 1,3 | 1,6 | 0,3 | -81,1 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | 0,1 | 46,4 |
Working assets | 0,8 | 0,7 | 0,4 | -45,6 |
Depreciation | 0 | 0 | 0 | 1420,3 |
Basic operational activity income | 124,2 | |||
% | % | % | p.p. | |
Profitability of capital | -110,1 | 11,5 | -114 | -125,5 |
Equity capital to total assets | 81,1 | 93,5 | 82 | -11,5 |
Gross profit margin | -55,4 | 5,5 | -134,3 | -139,8 |
EBITDA Margin | -61,5 | 4,9 | -137,2 | -142,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 42 | 12 | 94 | 82 |
Current financial liquidity indicator | 5.279576778411865 | -1,4 | ||
Net dept to EBITDA | 0.1953718662261963 | -0,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Wamed-Lab sp. z o.o.
Warszawa
Sis-Med sp. z o.o.
Łódź
Cannabis Sklep
Świętochłowice, woj. śląskie, Polska
HS Medical Poland
Tychy
Med Digital sp. z o.o.
Warszawa
"FARMEDICA" sp. z o.o.
Warszawa
KGU Konsult Wojciech Guzowski
Warszawa
Mi-Ro S.C.
Stróża